MARC record from Internet Archive

LEADER: 08568cam 2201081Ma 4500
001 ocm70731046
003 OCoLC
005 20200511032918.0
008 010924s2002 enka ob 001 0 eng d
006 m o d
007 cr cn|||||||||
010 $z 2001043946
040 $aREDDC$beng$epn$cREDDC$dBAKER$dOCLCQ$dN$T$dYDXCP$dAU@$dOCLCQ$dDKDLA$dMERUC$dCCO$dE7B$dMHW$dIDEBK$dOCLCQ$dEBLCP$dOCLCO$dOCLCQ$dOCLCF$dOCLCQ$dNLGGC$dOCLCQ$dAUD$dOCLCQ$dLOA$dAZK$dOCLCQ$dOCLCO$dOCLCA$dAGLDB$dTOA$dOCLCO$dMOR$dPIFBR$dZCU$dOCLCO$dOCLCQ$dOCLCO$dOCLCQ$dAL5MG$dOCLCO$dOCLCA$dU3W$dOCLCA$dUAB$dSTF$dWRM$dOCLCQ$dVTS$dNRAMU$dICG$dVT2$dOCLCQ$dOCLCO$dWYU$dOCLCO$dOCLCA$dREC$dCOCUF$dOCLCQ$dG3B$dOCLCO$dDKC$dOCLCQ$dOCLCO$dOCLCQ$dOCLCO$dK6U$dOCLCA$dUKCRE
019 $a56324356$a191035509$a271787879$a473965841$a488399236$a559155665$a646719871$a776949301$a814261370$a819627608$a824532198$a888683332$a960205746$a961671294$a962595628$a988518952$a991982263$a1035653148$a1037710832$a1038589545$a1045490249$a1055380858$a1058070139$a1064144918$a1153453455
020 $a0521806178$q(hbk.)
020 $a9780521806176$q(hbk.)
020 $a051104173X$q(electronic bk.)
020 $a9780511041730$q(electronic bk.)
020 $a0511044100
020 $a9780511044106
020 $a0511119712$q(electronic bk.)
020 $a9780511119712$q(electronic bk.)
020 $a9780511543944$q(ebook)
020 $a0511543948$q(ebook)
020 $a1280154918
020 $a9781280154911
020 $a0511007450
020 $a9780511007453
035 $a(OCoLC)70731046$z(OCoLC)56324356$z(OCoLC)191035509$z(OCoLC)271787879$z(OCoLC)473965841$z(OCoLC)488399236$z(OCoLC)559155665$z(OCoLC)646719871$z(OCoLC)776949301$z(OCoLC)814261370$z(OCoLC)819627608$z(OCoLC)824532198$z(OCoLC)888683332$z(OCoLC)960205746$z(OCoLC)961671294$z(OCoLC)962595628$z(OCoLC)988518952$z(OCoLC)991982263$z(OCoLC)1035653148$z(OCoLC)1037710832$z(OCoLC)1038589545$z(OCoLC)1045490249$z(OCoLC)1055380858$z(OCoLC)1058070139$z(OCoLC)1064144918$z(OCoLC)1153453455
050 4 $aRM315$b.P446 2002eb
060 4 $a2002 L-718
060 4 $aQV 38$bP3195 2002
072 7 $aMED$x093000$2bisacsh
072 7 $aMED$x105020$2bisacsh
072 7 $aMMH$2bicssc
082 04 $a615/.788$221
245 00 $aPharmacogenetics of psychotropic drugs /$cedited by Bernard Lerer.
260 $aCambridge, UK ;$aNew York :$bCambridge University Press,$c2002.
300 $a1 online resource (x, 446 pages) :$billustrations (some color)
336 $atext$btxt$2rdacontent
337 $acomputer$bc$2rdamedia
338 $aonline resource$bcr$2rdacarrier
347 $adata file$2rda
504 $aIncludes bibliographical references and index.
505 00 $gPart I : Introduction --$tGenes and psychopharmacology: exploring the interface /$rBernard Lerer --$gPart II : Clinical background and research design --$tFrom pharmacogenetics to pharmacogenomics of psychotropic drug response /$rAnil K. Malhotra --$tNeuropsychopharmacology: the interface between genes and psychiatric nosology /$rThomas A. Ban --$tMethodological issues in psychopharmacogenetics /$rSheldon H. Preskorn --$tStatistical approaches in psychopharmacogenetics /$rFabio Macciardi --$gPart III : Molecular background --$tPsychopharmacogenetic-neurodevelopmental interface in serotonergic gene pathways /$rK. Peter Lesch, Jens Benninghoff, Angelika Schmitt --$tRNA processing regulation and interindividual variation /$rColleen M. Niswender, Linda K. Hutchinson --$gPart IV : Pharmacokinetics --$tPharmacogenetics of psychotropic drug metabolism /$rVural Ozdemir [and others] --$tPharmacogenetics of chiral psychotropic drugs /$rPierre Baumann, Chin B. Eap --$gPart V : Specific psychotropic drugs and disorders --$tClozapine response and genetic variation in neurotransmitter receptor targets /$rDavid A. Collier [and others] --$tGenetic factors underlying drug-induced tardive dyskinesia /$rRonnen H. Segman, Bernard Lerer --$tFunctional gene-linked polymorphic regions in pharmacogenetics /$rMarco Catalano --$tAlternative phenotypes and the pharmacogenetics of mood and anxiety disorders /$rEmanuela Mundo, James L. Kennedy --$tPharmacogenetics of anxiolytic drugs and the GABA-benzodiazepine receptor complex /$rSmita A. Pandit [and others] --$tGenetic factors and long-term prophylaxis in bipolar disorder /$rMartin Alda --$tGenetic influences on responsiveness to anticonvulsant drugs /$rThomas N. Ferraro --$tApolipoprotein E as a marker in the treatment of Alzheimer's disease /$rKeith Schappert, Pierre Sevigny, Judes Poirier --$tGenetic variation and drug dependence risk factors /$rJoel Gelernter, Henry Kranzler --$gPart IV : Pharmacogenetics and brain imaging --$tBrain imaging and pharmacogenetics in Alzheimer's disease and schizophrenia /$rSteven G. Potkin, James L. Kennedy, Vincenzo S. Basile --$gPart VII : Industry perspectives --$tPharmacogenetics in psychotropic drug discovery and development /$rWilliam Z. Potter, AnnCatherine Van Lone, Larry Altstiel --$tHigh-throughput single nucleotide polymorphism genotyping /$rAnne Shalom, Ariel Darvasi.
520 $aProvides a conceptual framework for understanding and studying the pharmacogenetics of psychotropic drugs, reviews advances in the field, and describes the findings that have already emerged. Coverage extends to antipsychotics, antidepressants, mood stabilizing, cognitive-enhancing and anxiolytic drugs. An essential reference for all clinicians and researchers working in this field.
588 0 $aPrint version record.
650 0 $aPsychotropic drugs.
650 0 $aPharmacogenetics.
650 2 $aPharmacogenetics.
650 2 $aPsychotropic Drugs.
650 7 $aMEDICAL$xPain Medicine.$2bisacsh
650 7 $aMEDICAL$xPsychiatry$xPsychopharmacology.$2bisacsh
650 7 $aPharmacogenetics.$2fast$0(OCoLC)fst01060243
650 7 $aPsychotropic drugs.$2fast$0(OCoLC)fst01081826
653 $aElectronic books.
655 0 $aElectronic books.
655 4 $aElectronic books.
700 1 $aLerer, Bernard.
776 08 $iPrint version:$tPharmacogenetics of psychotropic drugs.$dCambridge, UK ; New York : Cambridge University Press, 2002$w(DLC) 2001043946
856 40 $3Ebook Library$uhttp://public.eblib.com/choice/publicfullrecord.aspx?p=202068
856 40 $3Ebook Library$uhttp://qut.eblib.com.au/patron/FullRecord.aspx?p=202068
856 40 $3ebrary$uhttp://site.ebrary.com/id/10062683
856 40 $3EBSCOhost$uhttps://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=112592
856 40 $3MyiLibrary$uhttp://www.myilibrary.com?id=15491
856 40 $3ProQuest Ebook Central$uhttp://public.ebookcentral.proquest.com/choice/publicfullrecord.aspx?p=202068
856 40 $uhttps://doi.org/10.1017/CBO9780511543944$zConnect to e-book
856 40 $uhttp://www.survey.bris.ac.uk/standrews/cambridgebooksonlinetrial$zWe have trial access to this e-book until 31/7/2012 through our Cambridge Books Online trial of over 12,000 titles. Please tell us if you would like to recommend continued access to it
856 40 $uhttp://VH7QX3XE2P.search.serialssolutions.com/?V=1.0&L=VH7QX3XE2P&S=JCs&C=TC0000220628&T=marc&tab=BOOKS$zVIEW FULL TEXT
856 41 $3MyiLibrary, Table of contents$uhttp://www.myilibrary.com?id=15491&ref=toc
856 41 $3Table of contents$uhttp://catdir.loc.gov/catdir/toc/cam027/2001043946.html
856 42 $3Contributor biographical information$uhttp://catdir.loc.gov/catdir/enhancements/fy0731/2001043946-b.html
856 42 $3Publisher description$uhttp://catdir.loc.gov/catdir/description/cam022/2001043946.html
856 40 $uhttp://ebookcentral.proquest.com/lib/ucreative-ebooks/detail.action?docID=202068$zConnect to Ebook.
938 $aBaker & Taylor$bBKTY$c200.00$d200.00$i0521806178$n0003807232$sactive
938 $aEBL - Ebook Library$bEBLB$nEBL202068
938 $aebrary$bEBRY$nebr10062683
938 $aEBSCOhost$bEBSC$n112592
938 $aProQuest MyiLibrary Digital eBook Collection$bIDEB$n15491
938 $aYBP Library Services$bYANK$n2826012
938 $aYBP Library Services$bYANK$n2616718
938 $aYBP Library Services$bYANK$n3275969
938 $aYBP Library Services$bYANK$n2300718
029 1 $aAU@$b000040656801
029 1 $aAU@$b000042831938
029 1 $aAU@$b000051401771
029 1 $aAU@$b000053242671
029 1 $aDEBBG$bBV043145744
029 1 $aDEBBG$bBV044078538
029 1 $aDEBSZ$b422377163
029 1 $aNZ1$b11925058
994 $aZ0$bP4A
948 $hHELD BY P4A - 1601 OTHER HOLDINGS